BC scientists coax gold particles to emit light strong enough to view single nanoparticles
Findings have implications for tracking disease, drugs at the molecular level
Researchers in the laboratory of Boston College Chemistry Professor John T. Fourkas have demonstrated that gold particles comparable in size to a molecule can be induced to emit light so strongly that it is readily possible to observe a single nanoparticle. Fourkas, in collaboration with postdoctoral researcher Richard Farrer and BC undergraduates Francis Butterfield and Vincent Chen, coaxed the particles into strong emission of visible light using a technique called multiphoton absorption induced luminescence (MAIL).
The most efficient gold nanoparticles could be observed at laser intensities lower than those commonly used for multiphoton imaging, in which specific tissues or cells -- cancer cells, for example -- are fluorescently-labeled using special stains that enable them to be studied.
"One of the most exciting aspects of this technique is that it paves the way for being able to observe behavior in living tissues at the single molecule level," said Fourkas. "The fluorescent molecules commonly used in multiphoton imaging give out only a limited amount of light, 'burn out' quickly under continuous observation, and are prone to blinking on and off.
"The gold particles, however, do not blink or burn out, even after hours of observation, and the brightest ones emit much more light than do molecules," he said. "We now have the ability to see single nanoparticles under conditions where people usually look at thousands or millions of stain molecules. This could allow us, for instance, to track a single molecule of a drug in a cell or other biological sample."
Other advantages of the technique are that the gold particles can be prepared easily, have very low toxicity, and can readily be attached to molecules of biological interest, said Fourkas. In addition, the laser light used to visualize the particles is at a wavelength range that causes only minimal damage to most biological tissue.
The findings will be published in the June issue of Nano Letters.
Most read news
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Enantiomorph distribution maps for metals and metallic alloys
Researchers find metal gets stronger with three or more line dislocations
General Lab and Labco to create a leading European medical diagnostics Group
A new iconic drug information system inspired by road signs
The Science Advisory Board report shows increase in usage of key protein research techniques
Science on the back burner: European laboratories struggle with massive restrictions - Great sustainability ambitions and willingness to innovate despite the need to save money
Genzyme Launches Key Test To Monitor Gleevec Resistance - Two Additional Personalized Medicine Tests Also Available
Michael Siekiera joins management board at Hahnemühle
Measurement of lower aldehydes especially acrolein with the 2-HMP method - GC method
BIOTECON Diagnostics signs license agreement with Applera Corporation